Forecast: Sold Production of Pharmaceutical Preparations in Sweden

The sold production of pharmaceutical preparations in Sweden has exhibited significant fluctuations from 2013 to 2023, beginning with a low of 92.605 million Euros in 2013 and peaking at 7276.7 million Euros in 2020. Notably, 2020 marked a tremendous growth of 82.43%, which then sharply declined by 78.88% in 2021, before experiencing a substantial rebound. By 2023, the production value slightly increased by 4.64%, standing at 3365.9 million Euros.

Over the five years from 2019 to 2023, the compound annual growth rate (CAGR) was 34.54%, demonstrating considerable growth despite interim volatility. The forecast for 2024 to 2028 shows a moderated yet steady growth with a CAGR of 3.08%, projecting continued increases in production value.

Future trends to watch for include:

• Potential market stabilization following recent extreme volatility.
• Increased investment in pharmaceutical innovation and technology.
• Regulatory changes impacting production and market dynamics.